<DOC>
	<DOCNO>NCT01028768</DOCNO>
	<brief_summary>To evaluate effect renal impairment pharmacokinetics ( PK ) teduglutide follow subcutaneous ( SC ) administration 10 mg teduglutide . Secondary objective assess safety tolerability 10 mg teduglutide . A objective description PK teduglutide follow SC administration 10 mg teduglutide elderly ( â‰¥ 65 year ) healthy subject compare non elderly healthy subject .</brief_summary>
	<brief_title>Pharmacokinetics 10 mg Teduglutide Subjects With Renal Impairment Compared Healthy Subjects With Normal Renal Function</brief_title>
	<detailed_description>Pharmacokinetic study .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Subjects moderate , severe end stage renal failure match healthy control .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Renal impairment</keyword>
	<keyword>Renal impairment study</keyword>
</DOC>